• 1
    Dunbar, P. R. and Ogg, G. S., Oligomeric MHC molecules and their homologues: state of the art. J. Immunol. Methods 2002. 268: 37.
  • 2
    Topalian, S. L., MHC class II restricted tumor antigens and the role of CD4+ T cells in cancer immunotherapy. Curr. Opin. Immunol. 1994. 6: 741745.
  • 3
    Hung, K., Hayashi, R., Lafond-Walker, A., Lowenstein, C., Pardoll, D. and Levitsky, H., The central role of CD4(+) T cells in the antitumor immune response. J. Exp. Med. 1998. 188: 23572368.
  • 4
    Kalams, S. A. and Walker, B. D., The critical need for CD4 help in maintaining effective cytotoxic T lymphocyte responses. J. Exp. Med. 1998. 188: 21992204.
  • 5
    Toes, R. E., Ossendorp, F., Offringa, R. and Melief, C. J., CD4 T cells and their role in antitumor immune responses. J. Exp. Med. 1999. 189: 753756.
  • 6
    Liu, C. P., Jiang, K., Wu, C. H., Lee, W. H. and Lin, W. J., Detection of glutamic acid decarboxylase-activated T cells with I-Ag7 tetramers. Proc. Natl. Acad. Sci. USA 2000. 97: 1459614601.
  • 7
    Homann, D., Teyton, L. and Oldstone, M. B., Differential regulation of antiviral T-cell immunity results in stable CD8+ but declining CD4+ T-cell memory. Nat. Med. 2001. 7: 913919.
  • 8
    Schepers, K., Toebes, M., Sotthewes, G., Vyth-Dreese, F. A., Dellemijn, T. A., Melief, C. J., Ossendorp, F. and Schumacher, T. N., Differential kinetics of antigen-specific CD4+ and CD8+ T cell responses in the regression of retrovirus-induced sarcomas. J. Immunol. 2002. 169: 31913199.
  • 9
    Novak, E. J., Liu, A. W., Nepom, G. T. and Kwok, W. W., MHC class II tetramers identify peptide-specific human CD4(+) T cells proliferating in response to influenza A antigen. J. Clin. Invest. 1999. 104: R63R67.
  • 10
    Meyer, A. L., Trollmo, C., Crawford, F., Marrack, P., Steere, A. C., Huber, B. T., Kappler, J. and Hafler, D. A., Direct enumeration of Borrelia-reactive CD4 T cells ex vivo by using MHC class II tetramers. Proc. Natl. Acad. Sci. USA 2000. 97: 1143311438.
  • 11
    Day, C. L., Seth, N. P., Lucas, M., Appel, H., Gauthier, L., Lauer, G. M., Robbins, G. K., Szczepiorkowski, Z. M., Casson, D. R., Chung, R. T., Bell, S., Harcourt, G., Walker, B. D., Klenerman, P. and Wucherpfennig, K. W., Ex vivo analysis of human memory CD4 T cells specific for hepatitis C virus using MHC class II tetramers. J. Clin. Invest. 2003. 112: 831842.
  • 12
    Seder, R. A. and Ahmed, R., Similarities and differences in CD4+ and CD8+ effector and memory T cell generation. Nat. Immunol. 2003. 4: 835842.
  • 13
    Reichstetter, S., Ettinger, R. A., Liu, A. W., Gebe, J. A., Nepom, G. T. and Kwok, W. W., Distinct T cell interactions with HLA class II tetramers characterize a spectrum of TCR affinities in the human antigen-specific T cell response. J. Immunol. 2000. 165: 69946998.
  • 14
    Kwok, W. W., Liu, A. W., Novak, E. J., Gebe, J. A., Ettinger, R. A., Nepom, G. T., Reymond, S. N. and Koelle, D. M., HLA-DQ tetramers identify epitope-specific T cells in peripheral blood of herpes simplex virus type 2-infected individuals: direct detection of immunodominant antigen-responsive cells. J. Immunol. 2000. 164: 42444249.
  • 15
    Danke, N. A. and Kwok, W. W., HLA class II-restricted CD4+ T cell responses directed against influenza viral antigens postinfluenza vaccination. J. Immunol. 2003. 171: 31633169.
  • 16
    Reijonen, H. and Kwok, W. W., Use of HLA class II tetramers in tracking antigen-specific T cells and mapping T-cell epitopes. Methods 2003. 29: 282288.
  • 17
    Stern, L. J. and Wiley, D. C., The human class II MHC protein HLA-DR1 assembles as empty alpha beta heterodimers in the absence of antigenic peptide. Cell 1992. 68: 465477.
  • 18
    Cunliffe, S. L., Wyer, J. R., Sutton, J. K., Lucas, M., Harcourt, G., Klenerman, P., McMichael, A. J. and Kelleher, A. D., Optimization of peptide linker length in production of MHC class II/peptide tetrameric complexes increases yield and stability, and allows identification of antigen-specific CD4+T cells in peripheral blood mononuclear cells. Eur. J. Immunol. 2002. 32: 33663375.
  • 19
    Texier, C., Pouvelle, S., Busson, M., Herve, M., Charron, D., Menez, A. and Maillere, B., HLA-DR restricted peptide candidates for bee venom immunotherapy. J. Immunol. 2000. 164: 31773184.
  • 20
    Reddy, J., Bettelli, E., Nicholson, L., Waldner, H., Jang, M. H., Wucherpfennig, K. W. and Kuchroo, V. K., Detection of autoreactive myelin proteolipid protein 139–151-specific T cells by using MHC II (IAs) tetramers. J. Immunol. 2003. 170: 870877.
  • 21
    Bischof, F., Hofmann, M., Schumacher, T. N., Vyth-Dreese, F. A., Weissert, R., Schild, H., Kruisbeek, A. M. and Melms, A., Analysis of autoreactive CD4 T cells in experimental autoimmune encephalomyelitis after primary and secondary challenge using MHC class II tetramers. J. Immunol. 2004. 172: 28782884.
  • 22
    Hao, M., Mukherjee, S. and Maxfield, F. R., Cholesterol depletion induces large scale domain segregation in living cell membranes. Proc. Natl. Acad. Sci. USA 2001. 98: 1307213077.
  • 23
    Drake, D. R., 3rd and Braciale, T. J., Cutting edge: lipid raft integrity affects the efficiency of MHC class I tetramer binding and cell surface TCR arrangement on CD8+ T cells. J. Immunol. 2001. 166: 70097013.
  • 24
    Daniels, M. A. and Jameson, S. C., Critical role for CD8 in T cell receptor binding and activation by peptide/major histocompatibility complex multimers. J. Exp. Med. 2000. 191: 335346.
  • 25
    Xu, X. N., Purbhoo, M. A., Chen, N., Mongkolsapaya, J., Cox, J. H., Meier, U. C., Tafuro, S., Dunbar, P. R., Sewell, A. K., Hourigan, C. S., Appay, V., Cerundolo, V., Burrows, S. R., McMichael, A. J. and Screaton, G. R., A novel approach to antigen-specific deletion of CTL with minimal cellular activation using alpha3 domain mutants of MHC class I/peptide complex. Immunity 2001. 14: 591602.
  • 26
    Boniface, J. J., Rabinowitz, J. D., Wulfing, C., Hampl, J., Reich, Z., Altman, J. D., Kantor, R. M., Beeson, C., McConnell, H. M. and Davis, M. M., Initiation of signal transduction through the T cell receptor requires the multivalent engagement of peptide/MHC ligands. Immunity 1998. 9: 459466.
  • 27
    Cochran, J. R., Cameron, T. O. and Stern, L. J., The relationship of MHC-peptide binding and T cell activation probed using chemically defined MHC class II oligomers. Immunity 2000. 12: 241250.
  • 28
    You, S., Chen, C., Lee, W. H., Wu, C. H., Judkowski, V., Pinilla, C., Wilson, D. B. and Liu, C. P., Detection and characterization of T cells specific for BDC2.5 T cell-stimulating peptides. J. Immunol. 2003. 170: 40114020.
  • 29
    Lim, A., Baron, V., Ferradini, L., Bonneville, M., Kourilsky, P. and Pannetier, C., Combination of MHC-peptide multimer-based T cell sorting with the immunoscope permits sensitive ex vivo quantitation and follow-up of human CD8+ T cell immune responses. J. Immunol. Methods 2002. 261: 177194.
  • 30
    Mallet-Designe, V. I., Stratmann, T., Homann, D., Carbone, F., Oldstone, M. B. and Teyton, L., Detection of low-avidity CD4+ T cells using recombinant artificial APC: following the antiovalbumin immune response. J. Immunol. 2003. 170: 123131.
  • 31
    Lucas, M., Day, C. L., Wyer, J. R., Cunliffe, S. L., Loughry, A., McMichael, A. J. and Klenerman, P., Ex vivo phenotype and frequency of influenza virus-specific CD4 memory T cells. J. Virol. 2004. 78: 72847287.
  • 32
    Bodinier, M., Peyrat, M. A., Tournay, C., Davodeau, F., Romagne, F., Bonneville, M. and Lang, F., Efficient detection and immunomagnetic sorting of specific T cells using multimers of MHC class I and peptide with reduced CD8 binding. Nat. Med. 2000. 6: 707710.
  • 33
    Hewitt, C. R., Lamb, J. R., Hayball, J., Hill, M., Owen, M. J. and O'Hehir, R. E., Major histocompatibility complex independent clonal T cell anergy by direct interaction of Staphylococcus aureus enterotoxin B with the T cell antigen receptor. J. Exp. Med. 1992. 175: 14931499.
  • 34
    Helms, T., Boehm, B. O., Asaad, R. J., Trezza, R. P., Lehmann, P. V. and Tary-Lehmann, M., Direct visualization of cytokine-producing recall antigen-specific CD4 memory T cells in healthy individuals and HIV patients. J. Immunol. 2000. 164: 37233732.
  • 35
    Dietrich, P. Y., Walker, P. R., Schnuriger, V., Saas, P., Perrin, G., Guillard, M., Gaudin, C. and Caignard, A., TCR analysis reveals significant repertoire selection during in vitro lymphocyte culture. Int. Immunol. 1997. 9: 10731083.
  • 36
    thor Straten, P., Kirkin, A. F., Siim, E., Dahlstrom, K., Drzewiecki, K. T., Seremet, T., Zeuthen, J., Becker, J. C. and Guldberg, P., Tumor infiltrating lymphocytes in melanoma comprise high numbers of T-cell clonotypes that are lost during in vitro culture. Clin. Immunol. 2000. 96: 9499.
  • 37
    Fourneau, J. M., Cohen, H. and Van Endert, P. M., A chaperone-assisted high yield system for the production of HLA-DR4 tetramers in insect cells. J. Immunol. Methods 2004. 285: 253264.
  • 38
    Lamb, J. R., Eckels, D. D., Lake, P., Woody, J. N. and Green, N., Human T-cell clones recognize chemically synthesized peptides of influenza haemagglutinin. Nature 1982. 300: 6669.
  • 39
    Hennecke, J. and Wiley, D. C., Structure of a complex of the human alpha/beta T cell receptor (TCR) HA1.7, influenza hemagglutinin peptide, and major histocompatibility complex class II molecule, HLA-DR4 (DRA*0101 and DRB1*0401): insight into TCR cross-restriction and alloreactivity. J. Exp. Med. 2002. 195: 571581.
  • 40
    Pannetier, C., Cochet, M., Darche, S., Casrouge, A., Zoller, M. and Kourilsky, P., The sizes of the CDR3 hypervariable regions of the murine T-cell receptor beta chains vary as a function of the recombined germ-line segments. Proc. Natl. Acad. Sci. USA 1993. 90: 43194323.